Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 25, 2015 12:34 AM ET


Company Overview of Enanta Pharmaceuticals, Inc.

Key Executives for Enanta Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Jay R. Luly Ph.D.40 RelationshipsChief Executive Officer, President and Director58
Paul J. Mellett Jr.No RelationshipsChief Financial Officer and Senior Vice President of Finance & Administration59
Nathaniel S. Gardiner J.D.No RelationshipsSenior Vice President, General Counsel and Secretary60
Timothy D. Ocain Ph.D.10 RelationshipsSenior Vice President of New Product Strategy and Development56

Enanta Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Daniel Jan Ellens Ph.D. 35 RelationshipsLife Sciences Partners BV66
Jay R. Luly Ph.D. 40 RelationshipsEnanta Pharmaceuticals, Inc.58
Terry C. Vance 30 RelationshipsSaints Capital56
Stephen Buckley Jr. 26 RelationshipsEnanta Pharmaceuticals, Inc.64
Bruce L. A. Carter Ph.D. 211 RelationshipsXencor, Inc.71
View All Board Members

Enanta Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Jr.Stephen Buckley26 Relationships3 Executives
Compensation Committee Ph.D.Bruce L. A. Carter211 Relationships3 Executives
Nominating Committee Terry C. Vance30 Relationships5 Executives
Corporate Governance Committee Terry C. Vance30 Relationships5 Executives
Supervisory Board Ph.D.Daniel Jan Ellens35 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$751.8K
Compensation as of Fiscal Year 2014
Enanta Pharmaceuticals, Inc. CEO Compensation
Industry Average


The Clorox Company Announces Board Changes
May 15, 2015 12:46 PM ET
Ryan Announces Executive Changes
May 13, 2015 4:55 PM ET
Church & Dwight Co. Inc. Announces Executive Changes
May 07, 2015 10:45 AM ET
Monica Nassif Joins Aunt Fannie's Board of Directors
May 05, 2015 1:32 PM ET
SCA Announces Resignation of Rolf Börjesson as Member of the Board of Directors
May 04, 2015 5:57 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Enanta Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at